Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASR | P41180 | 5/20 | 0.48 |
| ▸ | CNR2 | P34972 | 9/20 | 0.47 |
| ▸ | CNR1 | P21554 | 6/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 3/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3076047 | 0.87 | MAPK1 (0.51) | CASRCNR2CNR1KDM4EALDH1A1 | |
| SCHEMBL3070635 | 0.87 | CNR2 (0.48) | CASRCNR2CNR1KDM4EALDH1A1 | |
| SCHEMBL3074506 | 0.86 | ALDH1A1 (0.48) | CASRCNR2CNR1KDM4EALDH1A1 | |
| SCHEMBL3080921 | 0.85 | CNR2 (0.48) | CASRCNR2CNR1KDM4EALDH1A1 | |
| SCHEMBL3074521 | 0.85 | CNR2 (0.49) | CASRCNR2CNR1KDM4EALDH1A1 | |
| SCHEMBL3057487 | 0.84 | CNR2 (0.50) | CASRCNR2CNR1 | |
| SCHEMBL3080512 | 0.82 | CASR (0.49) | CASRCNR2CNR1KDM4EALDH1A1 | |
| SCHEMBL3067233 | 0.82 | HSD11B1 (0.55) | CNR2CNR1 | |
| SCHEMBL3063101 | 0.82 | CNR2 (0.49) | CASRCNR2CNR1ALDH1A1HTT | |
| SCHEMBL3063433 | 0.82 | TSHR (0.49) | CASRCNR2CNR1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2178845-B1 | INHIBITORS OF 11B-HYDROXYSTEROID DEHYDROGENASE | HOFFMANN LA ROCHE (CH) | 2013-06-19 | — | — | EP | claimed |
| US-7790711-B2 | Inhibitors of 11β-Hydroxysteroid Dehydrogenase | HOFFMANN-LA ROCHE INC. (US) | 2010-09-07 | — | — | US | claimed |
| US-20090023709-A1 | Inhibitors of 11B-Hyrdoxysteroid Dehydrogenase | GILLESPIE PAUL | 2009-01-22 | — | — | US | claimed |
| EP-2178845-B1 | INHIBITORS OF 11B-HYDROXYSTEROID DEHYDROGENASE | HOFFMANN LA ROCHE (CH) | 2013-06-19 | — | — | EP | disclosed |
| US-7790711-B2 | Inhibitors of 11β-Hydroxysteroid Dehydrogenase | HOFFMANN-LA ROCHE INC. (US) | 2010-09-07 | — | — | US | disclosed |
| EP-2178845-A2 | INHIBITORS OF 11B-HYDROXYSTEROID DEHYDROGENASE | F. Hoffmann-Roche AG (CH) | 2010-04-28 | — | — | EP | disclosed |
| US-20090023709-A1 | Inhibitors of 11B-Hyrdoxysteroid Dehydrogenase | GILLESPIE PAUL | 2009-01-22 | — | — | US | disclosed |
| WO-2009010416-A2 | INHIBITORS OF 11B-HYDROXYSTEROID DEHYDROGENASE | F. HOFFMANN-LA ROCHE AG (CH) | 2009-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023709-A1 | Inhibitors of 11B-Hyrdoxysteroid Dehydrogenase | HSD17B1, HSD17B2, HSD11B1 | CASR 4828/4885CNR2 4415/4885CNR1 4361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.